Defining the role of insulin detemir in Basal insulin therapy.

Defining the role of insulin detemir in Basal insulin therapy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Defining the role of insulin detemir in Basal insulin therapy. Abstract Text:

Javier Morales,Javier Morales,Javier Morales,

Insulin detemir is a novel long-acting insulin analogue with a unique mechanism underlying its prolonged duration of action. Unlike neutral protamine Hagedorn (NPH) insulin (insulin suspension isophane) and insulin glargine, which precipitate after administration, insulin detemir remains soluble after it is injected. The prolonged duration of action of insulin detemir is a result of the ability to self-associate into hexamers and dihexamers, and to bind reversibly to albumin. This mechanism of protraction provides a more prolonged, consistent and predictable glycaemic effect in patients with type 1 or type 2 diabetes mellitus compared with NPH insulin. Clinical studies have demonstrated that insulin detemir administered once or twice daily is at least as effective as NPH insulin and insulin glargine in achieving glycaemic control. Most trials have also shown that insulin detemir exhibits less intrapatient variability in glycaemic control compared with NPH insulin and insulin glargine. One of the benefits of insulin detemir is its favourable effect on bodyweight. Insulin detemir has shown weight neutrality in patients with type 1 diabetes and is associated with less weight gain than NPH insulin in clinical studies. Patients with type 2 diabetes using insulin detemir gain less weight than patients using NPH insulin and insulin glargine. In addition, a reduced risk of hypoglycaemia, particularly nocturnal hypoglycaemia, has been reported with insulin detemir compared with NPH insulin in patients with type 1 and type 2 diabetes. A reduced risk of major and nocturnal hypoglycaemia compared with insulin glargine in patients with type 1 diabetes has also been observed. Together, these data indicate that insulin detemir is a valuable new option for basal insulin therapy in patients with type 1 or type 2 diabetes.

Defining the role of insulin detemir in Basal insulin therapy. Publishing Authors By Initials

J Morales,J Morales,J Morales,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Defining the role of insulin detemir in Basal insulin therapy. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Drugs

VOLUME: 67

Page Numbers: 2557-84

Journal Abbreviation: Drugs

ISSN: 0012-6667

DAY: 23

MONTH: 11

YEAR: 2007

Defining the role of insulin detemir in Basal insulin therapy. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7600076

Defining the role of insulin detemir in Basal insulin therapy. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Defining the role of insulin detemir in Basal insulin therapy. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Defining the role of insulin detemir in Basal insulin therapy.

AFFILIATION: Advanced Internal Medicine Group, New Hyde Park, New York, USA.

Country: New Zealand

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Drugs

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Defining the role of insulin detemir in Basal insulin therapy Related Publications

• An attempt to detect phosphorylated myosin by ADP-ATP exchange.
• C-type natriuretic peptide and its relation to non-invasive indices of left ventricular function in patients with chronic heart failure.
• Chondrocyte moves: clever strategies?
• DPP10 is an inactivation modulatory protein of Kv4.3 and Kv1.4.
• Defining the role of insulin detemir in Basal insulin therapy.
• Development of an ultra-performance liquid chromatography technique coupled with mass spectrometry for the measurement of tacrolimus in micro-samples of whole blood, and its application on a pharmacokiinetic trial.
• Does the use of recombinant AAV2 in pulmonary gene therapy damage lung function?
• Effect of in vitro enzymatic digestion on antioxidant activity of coffee melanoidins and fractions.
• Fluorescence staining of glycerinated myofibrils with 1-anilino naphthalene-8-sulfonate.
• Frequency and causes of infectious abortion in a dairy herd in Queretaro, Mexico.
• GABAergic processes in the mesencephalic tegmentum modulate the occurrence of active (rapid eye movement) sleep in guinea pigs.
• Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation.
• Iron-deficiency anemia as presentation of pouchitis.
• Language access services for Latinos with limited English proficiency: lessons learned from Hablamos Juntos.
• Life-history strategies of plant pathogens: distribution patterns and phylogenetic analysis.
• Nanopore current transduction analysis of protein binding to non-terminal and terminal DNA regions: analysis of transcription factor binding, retroviral DNA terminus dynamics, and retroviral integrase-DNA binding.
• Noncholinesterase effects induced by organophosphate pesticides and their relationship to cognitive processes: implication for the action of acylpeptide hydrolase.
• P31.15: First results of biochemical screening and combined ultrasound of fetal chromosomal disorders in the first trimester of pregnancy in Ecuador.
• Patterns of early adherence to the antidepressant citalopram among older primary care patients: the prospect study.
• Protective effect of vitamin C towards N-nitrosamine-induced DNA damage in the single-cell gel electrophoresis (SCGE)/HepG2 assay.
• Relations and effects of transformational leadership: a comparative analysis with traditional leadership styles.
• Relationship Between Body Mass Index and Measures of Sport Participation in Junior Female Volleyball Players: 2143: Board #56 June 1 9:00 AM - 10:30 AM.
• Renal damage associated with proteinuria.
• Responding to human trafficking in Connecticut: a guide for health-care providers.
• Structural control over well productivity in the Jundiaí River Catchment, Southeastern Brazil.
• Synapses between corticotropin-releasing factor-containing axon terminals and dopaminergic neurons in the ventral tegmental area are predominantly glutamatergic.
• Unmasking the Brugada syndrome with high parasternal leads.
• Words of wisdom. Re: detection of circulating urothelial cancer cells in the blood using the CellSearch system.
• Xenopus laevis: a possible vector of ranavirus infection?
• [Introduction: clinical relevance of graft-induced immunological injury after renal transplantation]